Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

PHASE4CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

August 31, 2007

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

Ciclesonide nasal spray + placebo Azelastine

Ciclesonide nasal spray 50 mcg + Placebo Azelastine

DRUG

Ciclesonide nasal spray + Azelastine

Ciclesonide nasal spray 50 mcg + Azelastine 137 mcg

Trial Locations (35)

15241

Altana/Nycomed, Pittsburgh

19013

Altana/Nycomed, Upland

20814

Altana/Nycomed, Bethesda

23226

Altana/Nycomed, Richmond

23606

Altana/Nycomed, Newport News

27612

Altana/Nycomed, Raleigh

29414

Altana/Nycomed, Charleston

30281

Altana/Nycomed, Stockbridge

30501

Altana/Nycomed, Gainesville

31406

Altana/Nycomed, Savannah

43560

Altana/Nycomed, Sylvania

45231

Altana/Nycomed, Cincinnati

48375

Altana/Nycomed, Novi

53209

Altana/Nycomed, Milwaukee

65401

Altana/Nycomed, Rolla

66210

Altana/Nycomed, Overland Park

68046

Altana/Nycomed, Papillion

70006

Altana/Nycomed, Metairie

71105

Altana/Nycomed, Shreveport

75231

Altana/Nycomed, Dallas

78229

Altana/Nycomed, San Antonio

80206

Altana/Nycomed, Denver

80401

Altana/Nycomed, Lakewood

80907

Altana/Nycomed, Colorado Springs

90025

Altana/Nycomed, Los Angeles

92024

Altana/Nycomed, Encinitas

92123

Altana/Nycomed, San Diego

92691

Altana/Nycomed, Mission Viejo

95117

Altana/Nycomed, San Jose

97213

Altana/Nycomed, Portland

97504

Altana/Nycomed, Medford

97520

Altana/Nycomed, Ashland

02747

Altana/Nycomed, North Dartmouth

08558

Altana/Nycomed, Skillman

05403

Altana/Nycomed, South Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY